APT Medical Inc. (SHA:688617)
China · Delayed Price · Currency is CNY 227.40
+7.63 (3.47%)
Jul 31, 2026, 3:00 PM CST
APT Medical Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 2,724 | 2,584 | 2,066 | 1,650 | 1,216 | 828.69 |
Revenue Growth | 25.24% | 25.08% | 25.18% | 35.71% | 46.74% | 72.85% |
Gross Profit Gross Profit Growth | 1,974 | 1,877 | 1,486 | 1,164 | 861.98 | 569.61 |
Operating Income Operating Income Growth | 944.49 | 888.01 | 713.59 | 524.86 | 364.99 | 175.68 |
Net Income Net Income Growth | 866.92 | 820.64 | 673.15 | 533.92 | 358.02 | 207.92 |
Earnings Per Share EPS Growth | 6.13 | 5.80 | 4.76 | 3.77 | 2.52 | 1.51 |
EPS Growth | 20.97% | 21.85% | 26.41% | 49.38% | 67.20% | 42.79% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
China China Growth | 2,247 |
Overseas Overseas Growth | 336.77 |
Total Total Growth | 2,584 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,291 | 1,515 | 1,081 | 1,336 | 1,132 | 1,223 |
Total Debt Total Debt Growth | 14.55 | 19.4 | 11.29 | 89.86 | 52.59 | 46.58 |
Net Cash (Debt) Net Cash Growth | 1,276 | 1,496 | 1,070 | 1,247 | 1,080 | 1,177 |
Net Cash Growth | 7.82% | 39.79% | -14.18% | 15.46% | -8.26% | 1348.33% |
Net Cash Per Share Net Cash Per Share Growth | 9.02 | 10.57 | 7.56 | 8.79 | 7.60 | 8.53 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 993.29 | 967.76 | 743.39 | 689.06 | 367.46 | 181.39 |
Capital Expenditures CapEx Growth | -291 | -285.59 | -650.24 | -202.03 | -143.21 | -167.38 |
Free Cash Flow Free Cash Flow Growth | 702.29 | 682.17 | 93.15 | 487.03 | 224.25 | 14.01 |
Free Cash Flow Growth | 235.96% | 632.37% | -80.88% | 117.18% | 1500.56% | -86.53% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 72.48% | 72.62% | 71.93% | 70.54% | 70.88% | 68.74% |
Operating Margin | 34.68% | 34.37% | 34.54% | 31.81% | 30.01% | 21.20% |
Pretax Margin | 36.27% | 36.24% | 36.11% | 36.14% | 32.49% | 26.74% |
Profit Margin | 31.83% | 31.76% | 32.58% | 32.36% | 29.44% | 25.09% |
FCF Margin | 25.78% | 26.40% | 4.51% | 29.51% | 18.44% | 1.69% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 1.000 | 1.000 | 1.207 | 0.951 | 0.785 | 0.476 |
Dividend Per Share Growth | -42.86% | -17.14% | 26.88% | 21.20% | 65.01% | 100.00% |
Dividend Yield | 0.44% | 0.41% | 0.47% | 0.52% | 0.55% | 0.36% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 37.11 | 41.81 | 53.62 | 48.42 | 57.16 | 89.78 |
Forward PE | 32.28 | 33.30 | 41.69 | 41.48 | 50.33 | 65.88 |
P/FCF Ratio | 45.70 | 50.29 | 387.51 | 53.09 | 91.25 | 1332.38 |
PS Ratio | 11.78 | 13.28 | 17.47 | 15.67 | 16.83 | 22.53 |